|
Market Closed -
Toronto S.E.
15:59:59 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 3.620 CAD | -0.55% |
|
-0.28% | +34.07% |
| 07-28 | BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | BioRem Q2 Net Earnings Rise to C$0.11 Per Share | MT |
Evolution of the Average Target: BioRem Inc.
Evolution of the Target Price: BioRem Inc.
Changes in Analyst Recommendations: BioRem Inc.
08cdab10043eb.zBKZro26PCiPlR_Ry90M22ygyWbCdPwWSGchpPzyZlM.pif49tiOVUbB_XDoj4I5iSfVsyyzOpc7MggYwYq-PmW1dd3I_Ot-cvfGSg~7e673b6aaa89c4f8eaf618aa5d7e156e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +24.31% | |||
| +58.67% | |||||
| +8.39% | |||||
| +56.66% | |||||
| +56.94% | |||||
| - | - | +18.94% | |||
| +48.88% | |||||
| Average | +38.97% | |||||
| Weighted average by Cap. | +40.60% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.620CAD
Average target price
4.500CAD
Spread / Average Target
+24.31%
High Price Target
4.500CAD
Spread / Highest target
+24.31%
Low Price Target
4.500CAD
Spread / Lowest Target
+24.31%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- BRM Stock
- Consensus BioRem Inc.
Select your edition
All financial news and data tailored to specific country editions
